PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine and Science of Aging, Clinic of Infectious Diseases, University \'G. d\'Annunzio\' Chieti-Pescara, Chieti, Italy.\', \'Department of Medicine and Aging Sciences, Internal Medicine, \'G. D\'Annunzio\' University, Chieti, Italy.\', \'Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.\', \'Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, G. d\'Annunzio University of Chieti, Chieti, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/iid3.400
?:hasPublicationType
?:journal
  • Immunity, inflammation and disease
is ?:pmid of
?:pmid
?:pmid
  • 33465283
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • 3
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of canakinumab in mild or severe COVID-19 pneumonia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all